Genenta Science S.p.A. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur GNTA

Logo grafis genenta.com (GNTA)

The stability of Genenta Science S.p.A. (GNTA) development is ensured by the protection of US and EU medical regulations. On GURU.Markets, the annual sales growth rate (trailing 12 months) contains 0.00, which represents the latest level value. Success is based on the authority of European management and reporting transparency. The foundation consists of sophisticated laboratories and exclusive rights to viral vectors, which create a high barrier to entry for competitors.

Genenta Science (GNTA): Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 04.11.2026

Genenta Science (GNTA) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
Pambiji fundamental perusahaan:Genenta Science SpA
Barang unggulan genenta.com

For the long-term investor, Genenta Science (GNTA) represents a high-risk asset with an uncertain payback period. This metric measures the percentage change in total revenue over the last twelve months relative to the same period last year. By analyzing the LTM gross revenue dynamics, one can assess the stability of commercial flows. Given the early-stage nature of gene therapy research, the absence of proprietary revenue renders this indicator secondary. Current volatility confirms the business's total dependence on external financing.